-
1 Comment
Beijing Tiantan Biological Products Co., Ltd is currently in a long term uptrend where the price is trading 3.7% above its 200 day moving average.
From a valuation standpoint, the stock is 24.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.0.
Beijing Tiantan Biological Products Co., Ltd's total revenue rose by 12.7% to $1B since the same quarter in the previous year.
Its net income has increased by 23.0% to $213M since the same quarter in the previous year.
Finally, its free cash flow fell by 61.6% to $34M since the same quarter in the previous year.
Based on the above factors, Beijing Tiantan Biological Products Co., Ltd gets an overall score of 3/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000000WF9 |
| Sector | Healthcare |
| Industry | Biotechnology |
| PE Ratio | 25.77 |
|---|---|
| Target Price | 29.09 |
| Beta | 0.65 |
| Market Cap | 38B |
| Dividend Yield | None |
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. Beijing Tiantan Biological Products Co., Ltd. was founded in 1966 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600161.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
